Insmed (INSM) Stock Jumps Amid Encouraging Drug Development News
On Tuesday, shares of Insmed Incorporated (NASDAQ: INSM) increased significantly, closing at $90.93 after increasing 28.65%. The stock-price spike was sparked by the disclosure of encouraging results from a crucial Phase 2b clinical study evaluating its novel treatment for pulmonary arterial hypertension (PAH). Positive Results from the TPIP Study A randomized, double-blind, placebo-controlled Phase 2b […]